One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Bloomfield DJ, Chan C, Cleator S, Coles CE, Donovan E, Fleming H, Glynn D, Goodman A, Griffin S, Hopwood P, Kirby AM, Kirwan CC, Nabi Z, Patel J, Sawyer E, Somaiah N, Syndikus I, Venables K, Yarnold JR, Bliss JM; FAST-Forward Trial Management Group.
Brunt AM, et al. Among authors: hopwood p.
Health Technol Assess. 2023 Nov;27(25):1-176. doi: 10.3310/WWBF1044.
Health Technol Assess. 2023.
PMID: 37991196
Free PMC article.
Clinical Trial.